» Articles » PMID: 32179496

Response to "High CD44 Expression is Not a Prognosis Marker in Patients with High-risk Neuroblastoma"

Overview
Journal EBioMedicine
Date 2020 Mar 18
PMID 32179496
Authors
Affiliations
Soon will be listed here.
References
1.
Vega F, Colmenero-Repiso A, Gomez-Munoz M, Rodriguez-Prieto I, Aguilar-Morante D, Ramirez G . CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours. EBioMedicine. 2019; 49:82-95. PMC: 6945283. DOI: 10.1016/j.ebiom.2019.10.041. View